Opiate tolerance to daily heroin administration: An apparent phenomenon associated with enhanced pain sensitivity

Neuroscience

Volumn 89, Issue 3, 1999, Pages 631-636

  Laulin, J P ^a   Celerier E ^a   Larcher, A ^a   Le Moal, M ^a   Simonnet, G ^a  

^a INSERM   (France)

Author keywords

Analgesic effectiveness; Intermittent heroin administration; NMDA receptor antagonist; Opiate tolerance; Pain sensitivity; Rat

Indexed keywords

DIAMORPHINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANALGESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; MALE; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; FOOT; HEROIN; HYPERALGESIA; INJECTIONS, SUBCUTANEOUS; MALE; PAIN THRESHOLD; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; VOCALIZATION, ANIMAL;

EID: 0344097399     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00652-6     Document Type: Article

References (42)

1. Advokat C., Rhein F.Q. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA-antagonist dextrorphan. Brain Res. 699:1995;157-160.
2. Basbaum A.I. Insights into the development of opioid tolerance. Pain. 61:1995;349-352.
3. Ben-Eliyahu S., Marek P., Vaccarino A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
4. Bhargava H.N., Matwyshyn G.A. Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology. 47:1993;344-350.
5. Blasig J., Herz A., Reinhold K., Zieglgansberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of precipitated withdrawal syndrome in rats. Psychopharmacology. 331:1973;19-38.
6. Chen L., Huang L.Y. M. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron. 7:1991;319-326.
7. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature. 356:1992;521-523.
8. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
9. Collin E., Cesselin F. Neurobiological mechanisms of opioid tolerance and dependence. Clin. Neuropharmacol. 14:1991;465-488.
10. Colpaert F. System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmac. Rev. 48:1996;355-402.
11. Cox B. M. (1990) Drug tolerance and physical dependence. In Principles of Drug Action: The Basis of Pharmacology, 3rd edn (eds Pratt W. B. and Taylor P.), pp. 639-690. Churchill Livingstone, New York.
12. Dourish C.T., O'Neill M.F., Coughlan J., Kitchener S.J., Hawley D., Iversen S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmac. 176:1990;35-44.
13. Dubner R. (1991) Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. In Proc. VIth World Congress on Pain: Pain Research and Clinical Management (eds Bond M. R., Charlton J. E. and Woolf C. J.), pp. 263-276. Elsevier, Amsterdam.
14. Dunbar S.A., Pulai I.J. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. J. Pharmac. exp. Ther. 284:1998;678-686.
15. Elliott K., Hynansky A., Inturrisi C.E. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain. 59:1994;361-368.
16. Grisel J.E., Wieterlak E.P., Watkins L.R., Maier S.F. Route of administration modulates conditioned analgesic tolerance and hyperalgesia. Pharmac. Biochem. Behav. 49:1994;1029-1235.
17. Gutstein H.B., Trujillo K.A. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 626:1993;332-334.
18. Hoffmann O., Wiesenfeld-Hallin Z. The CCK-B receptor antagonist CI 988 reverse tolerance to morphine in rats. NeuroReport. 5:1994;2565-2568.
19. Hoffman O., Wiesenfeld-Hallin Z. Dextromethorphan potentiates morphine antinociception but does not reverse morphine tolerance in rats. NeuroReport. 7:1996;838-840.
20. Ibuki T., Dunbar S.A., Yaksh T.L. Effect of transient naloxone antagonism of tolerance development in rats receiving continuous spinal morphine infusion. Pain. 70:1997;125-132.
21. Jhamandas K.H., Marsala M., Ibuki T., Yaksh T.L. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci. 16:1996;2758-2766.
22. Kayan S., Woods L.A., Mitchell C.L. Morphine-induced hyperalgesia in rats tested on the hot plate. J. Pharmac. exp. Ther. 177:1971;509-513.
23. Kayser V., Guilbaud G. Can tolerance to morphine be induced in arthritics rats? Brain Res. 334:1985;335-338.
24. Kayser V., Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain. 41:1990;353-363.
25. Kim D.H., Fields H.L., Barbaro N.M. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes. Brain Res. 516:1990;37-40.
26. Larcher A., Laulin J.P., Célèrier E., Le Moal M., Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D- aspartate-dependent pain facilitatory systems. Neuroscience. 84:1998;583-589.
27. Laulin J.P., Larcher A., Célèrier E., Le Moal M., Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur. J. Neurosci. 10:1998;782-785.
28. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain. 67:1996;79-88.
29. Mao J., Price D.D., Caruso F.S., Mayer D.J. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain. 67:1996;361-368.
30. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
31. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
32. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
33. Marsala M., Malmberg A.B., Yaksh T.L. The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. J. Neurosci. Meth. 62:1995;43-53.
34. Mushlin B.E., Grell R., Cochin J. Studies on tolerance. I. The role of the interval between doses on the development of tolerance to morphine. J. Pharmac. exp. Ther. 196:1976;280-287.
35. Solomon R. L. (1991) Acquired motivation and affective opponent-processes. In Neurobiology of Learning and Affect (ed. Madden J. IV), pp. 307-347. Raven, New York.
36. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmac. 4:1993;289-312.
37. Tilson H.A., Rech R.H., Stolman S. Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia. 28:1973;287-300.
38. Tiseo P.J., Cheng J., Pasternak G.W., Inturrisi C.E. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J. Pharmac. exp. Ther. 268:1994;195-201.
39. Tiseo P.J., Inturrisi C.E. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY 274614. J. Pharmac. exp. Ther. 264:1993;1090-1096.
40. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
41. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies: what advantages do they offer for the control of pain syndromes? Drugs. 55:1998;1-14.
42. Yaksh T. L. (1993) The spinal actions of opioids. In Handbook of Experimental Pharmacology (ed. Herz A.), pp. 53-90. Springer-Verlag, Berlin Heidelberg.